CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- S-3MEF Other S-3MEF
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- ARS Other Annual Report to Security Holders
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market buy President - Asia Pacific bought 1,500 shares at $4.57 ($6,855)
- 4 Open-market buy Director bought 5,000 shares at $4.65 ($23,235)
- 4 Open-market buy Chief Financial Officer bought 6,000 shares at an average $4.29 ($25,741)
- 4 Open-market buy Director bought 5,000 shares at $4.83 ($24,164)
- 10-Q Report Quarterly Report
Page 52 of 74 · 1,465 filings